GCSG White Paper - Preparing for the Post-Brexit Clinical Supply Chain
4G Clinical is a proud sponsor of the 2018 US GCSG Conference in Atlanta and the resulting white paper on BREXIT considerations for clinical supply professionals. Here is a brief excerpt:
"For clinical trial sponsors and clinical supply vendors with research in the United Kingdom (UK) and/or the European Union (EU), changes are coming. With the UK scheduled to leave the EU on March 29, 2019, understanding how this will affect the clinical supply chain is critical to supporting ongoing research. While political negotiations are ongoing, and the exact outcome is unclear, the research industry needs to prepare now."
Amy Ripston, 4G Clinical Vice President of Marketing, has over 20 years of B2B experience, of which she spent 9 years in the bio/pharmaceutical industry. Amy has a knack for identifying market trends, synthesizing content, engaging thought leaders, and connecting businesses with innovative solutions.